RTW Investments, LP 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 08:49 am Sale | 2025-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | RTW Investments, LP | 23,407,133 8.300% | -1,776,154 (-7.05%) | Filing |
| 2025-08-14 08:10 am Purchase | 2025-06-30 | 13G | Taysha Gene Therapies, Inc. TSHA | RTW Investments, LP | 25,183,287 9.900% | 4,509,980 (+21.82%) | Filing |
| 2025-05-15 08:00 am Purchase | 2025-03-31 | 13G | Taysha Gene Therapies, Inc. TSHA | RTW Investments, LP | 20,673,307 9.990% | 8,304,973 (+67.15%) | Filing |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | RTW Investments, LP | 12,368,334 5.900% | -6,137,222 (-33.16%) | Filing |
| 2024-02-14 07:08 am Purchase | 2023-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | RTW Investments, LP | 18,505,556 9.800% | 18,505,556 (New Position) | Filing |